Mollan, S. P. http://orcid.org/0000-0002-6314-4437
Paemeleire, K.
Versijpt, J.
Luqmani, R.
Sinclair, A. J. http://orcid.org/0000-0003-2777-5132
Article History
Received: 16 September 2019
Accepted: 6 March 2020
First Online: 17 March 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: SPM – advisory board and speaker fees for Roche; speaker fees for Chugai-roche Ltd.KP - none relating to the manuscript.JV - none relating to the manuscript.RL - advisory board and speaker fees for Roche; speaker fees for AbbVie, Chugai-Roche Ltd.; grants from Celgene, Roche, Vifor.AS - speaker fees for Roche.